Compare YDES & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | EGY |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 615.4M |
| IPO Year | 2024 | 1996 |
| Metric | YDES | EGY |
|---|---|---|
| Price | $7.04 | $5.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.30 |
| AVG Volume (30 Days) | 701.4K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $359,272,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $29.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.70 | $3.36 |
| 52 Week High | $22.00 | $6.72 |
| Indicator | YDES | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 74.07 | 46.18 |
| Support Level | $1.99 | $5.56 |
| Resistance Level | $9.11 | $6.67 |
| Average True Range (ATR) | 0.82 | 0.19 |
| MACD | 0.26 | -0.06 |
| Stochastic Oscillator | 95.52 | 10.71 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.